STAAR Surgical Gains Amid Takeover Speculation
Global Ophthalmic Devices Market Analysis Report 2024-2032 Featuring Johnson & Johnson, Topcon, Canon, Alcon, STAAR Surgical, Glaukos, IRIDEX, Carl Zeiss
Express News | STAAR Surgical Co Shraes Hit Session Low as Volume Picks up, Last Down 6% at $44.58
STAAR Surgical Ticks Higher Amid Takeover Speculation
Watching STAAR Surgical; Traders Circulate Unconfirmed M&A Blog Comments Suggesting A European Group Is Rumored To Circling The Co
Watching STAAR Surgical; Traders Circulate Unconfirmed M&A Blog Comments Suggesting A European Group Is Rumored To Circling The Co
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Tempus AI, Inc. (NASDAQ:TEM) shares jumped 30.43% after the company announced it received U.S. FDA 510(k) cle
A Look At The Intrinsic Value Of STAAR Surgical Company (NASDAQ:STAA)
Key Insights The projected fair value for STAAR Surgical is US$52.71 based on 2 Stage Free Cash Flow to Equity Current share price of US$47.61 suggests STAAR Surgical is potentially trading close to
Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.
STAAR Surgical To Present At Goldman Sachs Global Healthcare Conference; Webcast At 8:00 AM ET
Staar Surgical Raised to Buy From Neutral by BTIG
Staar Surgical Raised to Buy From Neutral by BTIG
BTIG Upgrades Staar Surgical to Buy, Announces $46 Price Target
BTIG analyst Ryan Zimmerman upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy and announces $46 price target.
Staar Surgical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/11/2024 19.42% BTIG → $46 Upgrades Neutral → Buy 05/08/2024 — Needham Reiterates → Hold 05/08/2024 11.
BTIG Upgrades STAAR Surgical to Buy From Neutral, Price Target Is $46
STAAR Surgical (STAA) has an average rating of outperform and price targets ranging from $40 to $60, according to analysts polled by Capital IQ.
BTIG Upgrades Staar Surgical(STAA.US) to Buy Rating, Announces Target Price $46
BTIG analyst Ryan Zimmerman upgrades $Staar Surgical(STAA.US)$ to a buy rating, and sets the target price at $46.According to TipRanks data, the analyst has a success rate of 46.9% and a total average
Express News | STAAR Surgical Co : Btig Raises to Buy From Neutral
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $50
Stifel analyst Thomas Stephan maintains $Staar Surgical(STAA.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 71.4% and a tot
STAAR Surgical Company's (NASDAQ:STAA) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
STAAR Surgical (NASDAQ:STAA) has had a rough month with its share price down 8.7%. However, stock prices are usually driven by a company's financials over the long term, which in this case look pret
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, invites investors and
Is It Time To Consider Buying STAAR Surgical Company (NASDAQ:STAA)?